Shares of IBRX stock opened at $3.01 on Monday. The company has a market capitalization of $2.57 billion, a price-to-earnings ratio of -3.27 and a beta of 0.82. ImmunityBio has a one year low of ...
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a life sciences company developing innovative targeted oncology therapies and commercializing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback